Skin disorders in association with monoclonal gammopathies

European Journal of Medical Research

Volumn 10, Issue 3, 2005, Pages 93-104

  Harati, A ^a   Brockmeyer, N H ^a   Altmeyer, P ^a   Kreuter, Alexander ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DAPSONE; ETRETIN; ETRETINATE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARAPROTEIN; PENICILLAMINE; PREDNISONE; PROSTAGLANDIN E1; RETINOID; STEROID; SULFAMETHOXYPYRIDAZINE; SULFAPYRIDINE; UNINDEXED DRUG;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AMYLOIDOSIS; ARTICLE; B LYMPHOCYTE; BONE PAIN; CORRELATION ANALYSIS; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG FATALITY; DRUG MEGADOSE; ELECTRON BEAM; EPIDERMOLYSIS BULLOSA ACQUISITA; FEVER; HUMAN; HYPERVISCOSITY SYNDROME; ICHTHYOSIS; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY DISEASE; LASER SURGERY; LEUKOCYTOCLASTIC VASCULITIS; LYMPHOCYTE PROLIFERATION; LYMPHOMATOID PAPULOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NECROBIOTIC DISORDER; NEUTROPENIA; PARAPROTEINEMIA; PATHOGENESIS; PEMPHIGOID; PEMPHIGUS; PLASMA CELL; PLASMACYTOMA; PLASMAPHERESIS; PROGNOSIS; PUVA; PYODERMA GANGRENOSUM; SCHNITZLER SYNDROME; SCLEREDEMA; SCLEROMYXEDEMA; SEZARY SYNDROME; SKIN ABRASION; SKIN DISEASE; SUBCORNEAL PUSTULAR DERMATOSIS; URTICARIA PIGMENTOSA; XANTHOGRANULOMA; XANTHOMA;

HUMANS; PARAPROTEINEMIAS; SKIN DISEASES;

EID: 17144395108     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Alexanian R, Weber D, Liu F (1999) Differential diagnosis of monoclonal gammopathies. Arch Pathol Lab Med 123: 108-13
2. Arbetter KR, Hubbard KW, Markovic SN (1999) Case of granulocyte colony-stimulating factor-induced Sweet's syndrome. Am J Hematol 61: 126-9
3. Atukorala DN, Joshi RK, Abanmi A (1993) Subcorneal pustular dermatosis and IgA myeloma. Dermatology 187:124-6
4. August PJ, Wells GC. (1974) Pyoderma gangrenosum treated with azathioprine and prednisolone. Br J Dermatol 91: 80-2
5. Barosi G, Boccadoro M, Cavo M, et al. (2004) Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). Haematologica 89: 717-41
6. Bayer-Garner IB, Smoller BR (2003) Leukocytoclastic (small vessel) vasculitis in multiple myeloma. Clin Exp Dermatol 28: 521-4
7. Bennett ML, Jackson JM, Jorizzo JL, et al. (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 79: 37-46
8. Bergsagel D (1995) The incidence and epidemiology of plasma cell neoplasms. Stem Cells 13: 21-9
9. Behm FG, Kay S, Aportela R (1981) Febrile neutrophilic dermatosis associated with acute leukemia. Am J Clin Pathol 76: 344-7
10. Boatman BW, Taylor RC, Klein LE, Cohen BA (1994) Sweet's syndrome in children. South Med J 87: 193-6
11. Bolcskei L, Husz S, Hunyadi J, et al. (1992) Subcorneal pustular dermatosis and IgA multiple myeloma. J Dermatol 19: 626-8
12. Bourke JF, Keohane S, Long CC, et al. (1997) Sweet's syndrome and malignancy in the U.K. Br J Dermatol 137: 609-13
13. Bowen AR, Smith L, Zone JJ (2003) Scleredema adultorum of Buschke treated with radiation. Arch Dermatol 139: 780-4
14. Brigden ML (1999) The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance? Postgrad Med 106: 135-42
15. Brouet JC, Clauvel JP, Danon F, et al. (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57: 775-88
16. Bulfoni A (1995) Mixed cryoglobulinemia and the hepatitis C virus. Minerva Med 86: 193-8
17. Burruss JB, Farmer ER, Callen JP (1996) Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. J Am Acad Dermatol 35: 720-4
18. Bussel A (1993) Indications of plasma extraction during the treatment of monoclonal gammopathies. Rev Prat 43: 326-9
19. Callen JP (1998) Pyoderma gangrenosum. Lancet 351: 581-5
20. Christiaens I, Laloux M, Reychler H (1999) Oral amyloidosis and multiple myeloma. Apropos of a case and review of the literature. Rev Stomatol Chir Maxillofac 100: 245-9
21. Claudy A (1998) Pathogenesis of leukocytoclastic vasculitis. Eur J Dermatol 8: 75-78
22. Collet E, Dalac S, Guy H, et al. (1991) Cutaneous manifestations in multiple myeloma. Ann Dermatol Venereol 118: 35-44
23. Costa A, Barosi G, Piccolo G, et al. (1990) POEMS syndrome with IgA lambda monoclonal gammopathy. Haematologica 75: 170-2
24. Cron RQ, Swetter SM (1994) Scleredema revisited. A post-streptococcal complication. Clin Pediatr (Phila) 33: 606-10
25. Cuellar ML, Garcia C, Molina JF (1995) Cryoglobulinemia and other dysproteinemias, familial Mediterranean fever, and POEMS syndrome. Curr Opin Rheumatol 7: 58-64
26. Dammacco F, Sansonno D (1997) Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 15: 97-119
27. Daoud MS, Lust JA, Kyle RA, et al. (1999) Monoclonal gammopathies and associated skin disorders. J Am Acad Dermatol 40: 507-35
28. de Castro FR, Masouye I, Winkelmann RK, et al. (1996) Urticarial pathology in Schnitzler's (hyper-IgM) syndrome. Dermatology 193: 94-9
29. Dinneen AM, Dicken CH (1995) Scleromyxedema. J Am Acad Dermatol 33: 37-43
30. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al. (2000) Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 18: 214-26
31. Duggan DB, Schattner A (1986) Unusual manifestations of monoclonal gammopathies. Autoimmune and idiopathic syndromes. Am J Med 81: 864-70
32. Durani BK, Bock M, Naher H (2002) Extracorporeal photopheresis - treatment option in scleromyxedema? Hautarzt 52: 938-41
33. Gibson LE, Su WP (1995) Cutaneous vasculitis. Rheum Dis Clin North Am 21: 1097-113
34. Gibson LE, el-Azhary RA (2000) Erythema elevatum diutinum. Clin Dermatol 18: 295-9
35. Goldstein M, Bandyopadhyay T (2004) POEMS syndrome. Conn Med 68: 431-3
36. Harris RB, Perry HO, Kyle RA, et al. (1979) Treatment of scleromyxedema with melphalan. Arch Dermatol 115: 295-9
37. Hensley CD, Caughman SW (2000) Neutrophilic dermatoses associated with hematologic disorders. Clin Dermatol 18: 355-67
38. Herrinton LJ (1996) The epidemiology of monoclonal gammopathy of unknown significance: a review. Curr Top Microbiol Immunol 210: 389-95
39. Hidalgo Calleja C, Borbujo Martinez J, Diez Gomez JJ, et al. (1993) Diffuse normolipemic plane xanthoma with paraproteinemia, hypocomplementemia and joint involvement. Med Clin 100: 638-9
40. Hodak E, Tamir R, David M, et al. (1988) Scleredema adultorum associated with IgG-kappa multiple myeloma - a case report and review of the literature. Clin Exp Dermatol 13: 271-4
41. Iwasaki T, Kakishita E (1995) Cryoglobulinemia. Nippon Rinsho 53: 736-40
42. Jeanfils S, Joly P, Young P, et al. (1997) Indomethacin treatment of eighteen patients with Sweet's syndrome. J Am Acad Dermatol 36: 436-9
43. Kaufmann J, Hein G, Stein G (2003) Hypersensitivity vasculitis. Med Klin 98:19-29
44. Kohl PK, Hartschuh W, Tilgen W, et al. (1991) Pyoderma gangrenosum followed by subcorneal pustular dermatosis in a patient with IgA paraproteinemia. J Am Acad Dermatol 24: 325-8
45. Kumar A, Loughran T, Alsina M, et al. (2003) Management of multiple myeloma: a systematic review and critical appraisal of published studies. Lancet Oncol 4: 293-304
46. Kyle RA, Greipp PA (1998) Plasma cell dyscrasias: current status. Crit Rev Oncol Hematol 8: 9
47. Kyle RA (1999) Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 123: 114-8
48. Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351: 1860-73
49. Lagueny A, Bouillot S, Vital C, et al. (2004) POEMS syndrome (or Crow-Fukase syndrome). Rev Neurol 160: 285-95
50. Lee DD, Huang CY, Wong CK (1998) Dermatopathologic findings in 20 cases of systemic amyloidosis. Am J Dermatopathol 20: 438-42
51. Lipsker D (2002) The Schnitzler syndrome - a treatment at last? Dermatology 205: 1-2
52. Lotti T, Ghersetich I, Comacchi C, et al. (1998) Cutaneous small-vessel vasculitis. J Am Acad Dermatol 39: 667-87
53. Machado S, Alves R, Lima M, et al. (2001) Cutaneous necrobiotic xanthogranuloma (NXG)-successfully treated with low dose chlorambucil. Eur J Dermatol 1:458-62
54. Maillard H, Leclech C, Peria P, et al. (1999) Colchicine for Sweet's syndrome. A study of 20 cases. Br J Dermatol: 140(3): 565-6
55. Mijuskovic Z, Zecevic R, Pavlovic M (2004) Pyoderma gangrenosum with spleen involvement and monoclonal IgA gammopathy. J Eur Acad Dermatol Venereol 18: 697-9
56. Mehregan DA, Winkelmann RK (1992) Necrobiotic xanthogranuloma. Arch Dermatol 128: 94-100
57. Mussini C, Ghini M, Zanni G, et al. (1993) Cryoglobulinemia: a monoclonal gammopathy? Haematologica 78: 255-6
58. Nocente R, Cammarota G, Gentiloni Silveri N, et al. (2002) A case of Sweet's syndrome associated with monoclonal immunoglobulin of IgG-lambada type and P-ANCA positivity. Panminerva Med 44: 149-50
59. Piette WW (1986) Myeloma, paraproteinemias, and the skin. Med Clin North Am 70: 155-76
60. Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34: 395-409
61. Pujol JA, Bueno M, Fuertes MA, et al. (1995) Improvement of scleredema associated with IgA multiple myeloma after chemotherapy. Clin Exp Dermatol 20: 149-52
62. Reuss-Borst MA, Pawelec G, Saal JG, et al. (1993) Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol 84: 356-8
63. Roger H, Thevenet JP, Souteyrand P, et al. (1990) Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: simultaneous remission of skin and joint involvements with dapsone treatment. Ann Rheum Dis 49: 190-1
64. Roth S, Delmont E, Heinrich F, et al. (2002) Necrobiotic xanthogranuloma, a cutaneous disorder associated with monoclonal gammopathy. Rev Med Interne 23: 460-4
65. Sachdev DS, Kharkar VD, Mahajan SA, et al. (2002) Erythema elevatum diutinum. J Postgrad Med 48: 310-1
66. Saurat JH, Schifferli J, Steiger G, et al. (1991) Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition - higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 88: 244-56
67. Siami GA, Siami FS (1999). Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis. Ther Apher 3: 8-19
68. Sneddon IB (1977) Subcorneal pustular dermatosis. Hautarzt 28: 63-6
69. Sneddon IB, Wilkinson DS (1979) Subcorneal pustular dermatosis. Br J Dermatol 100: 61-8
70. Soubrier MJ, Dubost JJ, Sauvezie BJ (1994) POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 97: 543-53
71. Stone MS, Lyckholm LJ (1996) Pyoderma gangrenosum and subcorneal pustular dermatosis: clues to underlying immunoglobulin A myeloma. Am J Med 100: 663-4
72. Su WP, Liu HN (1986) Diagnostic criteria for Sweet's syndrome. Cutis 37: 167-74
73. Takatsuki K (1994) Takatsuki disease found in Japanese patients. Nippon Naika Gakkai Zasshi 83: 1476-82
74. Takata M, Inaoki M, Shodo M, et al. (1994) Subcorneal pustular dermatosis associated with IgA myeloma and intraepidermal IgA deposits. Dermatology 189: 111-4
75. Todd DJ, Bingham EA, Walsh M, et al. (1991) Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA. Br J Dermatol 125: 387-9
76. Tricot G, Barlogie B, Van Rhee F (2004) Treatment advances in multiple myeloma. Br J Haematol 125: 24-30
77. Ulmer A, Schaumburg-Lever G, Bauer J, et al. (1998) Scleredema adultorum Buschke. Case report and review of the literature. Hautarzt 49:48-54
78. Vaccaro M, Cannavo SP, Guarneri B (1999) Subcorneal pustular dermatosis and IgA lambda myeloma: a uncommon association but probably not coincidental. Eur J Dermatol 9: 644-6
79. Varterasian ML (1995) Biologic and clinical advances in multiple myeloma. Oncology (Huntingt) 9: 417-24
80. Vignon-Pennamen MD, Wallach D (1995) Neutrophilic disease: a review of extracutaneous manifestations. Eur J Dermatol 5: 449-55
81. von den Driesch P (1994) Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31: 535-56
82. Wayte JA, Rogers S, Powell FC (1995). Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy. Australas J Dermatol 36: 21-3
83. Wong CK (1990) Mucocutaneous manifestations in systemic amyloidosis. Clin Dermatol 8: 7-12
84. Wong TY, Suster S, Bouffard D, et al. (1995) Histologic spectrum of cutaneous involvement in patients with myelogenous leukemia including the neutrophilic dermatoses. Int J Dermatol 34: 323-9
85. Yiannias JA, El-Azhary RA, Gibson LE (1992) Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients. J Am Acad Dermatol 26: 38-44